Clinical Trial Update: Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day

View source ↗

Summary

This document provides an update on a clinical trial evaluating R(+) pramipexole dihydrochloride monohydrate at 60 mg/day for amyotrophic lateral sclerosis, wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• R(+) Pramipexole Dihydrochloride Monohydrate (pramipexole dihydrochloride monohydrate (R(+) enantiomer))

Snippet

Sponsor: Bennett, James P., Jr., M.D., Ph.D. | Conditions: Amyotrophic Lateral Sclerosis | Status: TEMPORARILY_NOT_AVAILABLE